Literature DB >> 21264806

Effect of hyperthyroidism on clearance and secretion of glucagon in man.

G Dimitriadis1, E Hatziagelaki, P Mitrou, V Lambadiari, E Maratou, A E Raptis, J E Gerich, S A Raptis.   

Abstract

OBJECTIVE: Glucagon has been proposed to contribute to the increased glucose production found in hyperthyroidism. However, fasting plasma glucagon levels are not increased in hyperthyroidism suggesting that the activity of the α-cell is normal. Nevertheless, an increase in the clearance rate of glucagon may mask increased glucagon secretion. This study was designed to examine the effects of hyperthyroidism on the kinetics of glucagon. DESIGN AND METHODS: A primed-continuous infusion of glucagon was administered to 9 euthyroid and 9 hyperthyroid subjects at 3 sequential rates (1,200, 3,000 and 6,000 pg/kg/min, each given for 2 h). Arterialized blood was drawn at 15-30 min intervals for determination of glucagon.
RESULTS: Fasting plasma glucagon levels were comparable in euthyroids (195±8 pg/ml) and hyperthyroids (231±16 pg/ml). During infusions (1,200, 3,000 and 6,000 pg/kg/min), plasma glucagon increased to 387±19, 624±44 and 977±51 pg/ml in euthyroids and to 348±23, 597±42 and 938±56 pg/ml in hyperthyroids respectively. At these infusion rates, metabolic clearance of glucagon (ml/kg/min) was 6.6±0.5, 7.4±0.6 and 7.9±0.5 in euthyroids and 12.6±2, 8.9±1 and 8.8±0.6 in hyperthyroids, respectively. Metabolic clearance of glucagon differed between hyperthyroids and euthyroids at 1 200 pg/kg/min infusion rate (p=0.001). The basal delivery rate of glucagon (ng/kg/min) was 1.3±0.1 in euthyroids and 2.9±0.6 in hyperthyroids (p=0.0005).
CONCLUSIONS: In hyperthyroidism, the secretion and metabolic clearance rates of glucagon are increased. These effects may explain the changes in plasma glucagon levels observed in hyperthyroidism and support the important role of glucagon in increasing endogenous glucose production in this condition. © J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21264806     DOI: 10.1055/s-0030-1269880

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  4 in total

1.  Glucose metabolism before and after radioiodine therapy of a patient with Graves' disease: Assessment by continuous glucose monitoring.

Authors:  Yun Hu; Gu Gao; Reng-Na Yan; Feng-Fei Li; Xiao-Fei Su; Jian-Hua Ma
Journal:  Biomed Rep       Date:  2017-06-21

Review 2.  Thyroid Dysfunction and Diabetes Mellitus: Two Closely Associated Disorders.

Authors:  Bernadette Biondi; George J Kahaly; R Paul Robertson
Journal:  Endocr Rev       Date:  2019-06-01       Impact factor: 19.871

3.  Circulating glucagon to ghrelin ratio as a determinant of insulin resistance in hyperthyroidism.

Authors:  Kemal Ağbaht; Murat Faik Erdogan; Rifat Emral; Nilgun Baskal; Sevim Güllü
Journal:  Endocrine       Date:  2013-04-10       Impact factor: 3.633

4.  Why can insulin resistance be a natural consequence of thyroid dysfunction?

Authors:  Gabriela Brenta
Journal:  J Thyroid Res       Date:  2011-09-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.